Vor Bio
The Director, Biostatistics at Vor Biosciences is a senior individual contributor who provides strategic and operational oversight of statistical activities across multiple clinical programs. The role involves designing clinical trials, ensuring regulatory compliance, leading data analysis and reporting, and collaborating cross-functionally within a lean biotech environment.
Vor Bio is a clinical-stage cell and genome engineering company developing novel hematopoietic stem cell-based therapies for cancer. The company is focused on transforming the treatment of hematological malignancies through engineered stem cell transplantation and targeted therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Vor Bio.
63% above the average for this role
Vor, with new CEO, changes course to target autoimmune disease
Jun 26, 2025